EOG — EOG Resources, Inc.
EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas in producing basins in the United States, the Republic of Trinidad and Tobago, and internationally. The company also offers crude oil and condensate, and gathering, processing and marketing.
Price chart & technical analysis
Loading chart…
As of 2026-09-13, EOG Resources traded at $147.36, sitting near the top of its 52-week range ($101.59-$153.67) after a blowout Q2 2026 (revenue $8.62B, diluted EPS $5.15). The stock is 13.8% above its 200-day SMA with RSI at 54.4 — a clean uptrend, but not a stretched one.
Sentiment is constructive but measured, not euphoric. The Q2 2026 print on 2026-08-04 beat on both lines (EPS $5.07 vs $4.97 consensus on the Street's number; revenue $8.62B vs $8.04B) and the stock has responded with a steady grind higher — +1.49% over one week, +2.95% over one month, +7.84% over three months and +10.3% over six months as of 2026-09-13. Sell-side targets were nudged up after the beat (Citigroup $141 to $150, Goldman Sachs $127 to $151, Wells Fargo Overweight with a $193 high target), and the ratings mix skews positive at 38 Buy vs 27 Hold and zero Sells. The tempering factor: consensus price target of $159.85 (recent average $158.64) implies only about 8% upside from $147.36, and RSI at 54.35 shows the market has not chased the stock into overbought territory. That is the profile of a market that likes the cash flow but is unwilling to capitalize commodity-levered earnings at a full multiple.
The three-year shape is a long plateau followed by a sharp 2026 inflection, with one seriously distorted quarter in the middle. Revenue sat in a narrow $5.36B-$6.11B band every quarter from Q3 2023 through Q4 2025, then broke out to $6.758B in Q1 2026 and $8.620B in Q2 2026 — roughly +61% year-over-year against Q2 2025's $5.355B and +27.6% sequentially, a genuine inflection rather than a blip. EPS tells the same story with a detour: $3.48 (Q3 2023) faded gradually to $2.95 (Q2/Q3 2024) and $2.23 (Q4 2024), then ran $2.65, $2.46, $2.70 through the first three quarters of 2025 before collapsing to $1.30 in Q4 2025 — and that quarter is the tell. Operating income was $2.489B but net income was only $701M, a roughly $1.0-1.2B gap versus the $600-800M below-the-line gap in a normal quarter, which points to a large one-off (impairment, derivative mark, or tax item) rather than an operating deterioration. The genuine operating trend is captured by operating margin: 41.8% in Q3 2023, compressing to a 28.2%-35.6% range across 2024, then recovering to 31.8%/32.6%/32.0% through 2025 and 38.4%/40.9% in Q1/Q2 2026 — roughly 830bp of year-over-year operating margin expansion in Q2 2026 (40.9% vs 32.6%). Free cash flow confirms it: TTM FCF is $6.726B, with Q2 2026 alone generating $2.887B against $1.782B of capex, versus a 2024 run-rate that never exceeded $2.086B in a quarter. Verdict: accelerating, and the acceleration is real, but it is commodity-price-levered rather than a structural margin story.
Fair-to-modestly-cheap, with the trailing multiple flattered by a one-off. As of 2026-09-13 the stock traded at 11.41x TTM EPS of $13.072, a ~9% premium to EOG's own 5-year average P/E of 10.47x, and at 2.93x sales versus a 5-year average P/S of 2.74x — the deterministic model labels this 'Neutral vs. its own history,' and that is right on the trailing numbers. But the trailing numbers are contaminated: Q4 2025's $1.30 EPS was a below-the-line casualty, and normalizing that quarter toward a typical ~$2.45 lifts TTM EPS to roughly $14, putting the trailing P/E back near 10.5x — dead on the historical average. On forward numbers it looks cheaper: $147.36 against next-FY consensus EPS of $16.692 is 8.83x, a PEG of 0.462, and EV/EBITDA of 5.75x. The cash-flow lens is the most flattering: $6.726B of TTM free cash flow on a $78.5B market cap is an 8.6% FCF yield, and the 2.917% dividend yield is covered roughly 4x by earnings with $11.7B still authorized for repurchase — about 15% of market cap. Net-net: not a bargain-bin multiple, but you are being paid a real cash yield to hold a fortress balance sheet at a below-market earnings multiple.
The stock has not fully priced in the earnings inflection, but it is close enough that the next leg depends on durability rather than re-rating. Price is up 7.84% over three months and 10.3% over six months as of 2026-09-13, while forward EPS expectations sit at $16.692 against a 5-year average P/E of 10.47x — meaning at 8.83x forward, the market is capitalizing this earnings stream at roughly a 15% discount to EOG's own historical multiple. The reason is obvious and rational: the $16.692 consensus embeds commodity prices near current levels, and the Street refuses to pay a full multiple for commodity-levered earnings near a cyclical high. That creates an asymmetric setup. If Q3 2026 confirms the volume and cost story (Delaware well costs down ~15%, sub-one-year payouts) at stable prices, the multiple can close toward 10x on $16.69 — that is your upside. If instead Q2 2026's +61% revenue jump was mostly realized-price, not volume and efficiency, then the $16.692 denominator erodes and the same 8.83x forward multiple becomes an 11-12x P/E on $13-14 of EPS — not cheap at all. Read the November print as a durability test, not a growth test.
As of 2026-09-13, RSI(14) stood at 54.35 — squarely neutral, with no overbought or oversold signal. Price at $147.36 sat 0.16% above its 20-day SMA (~$147.12), 3.18% above its 50-day SMA (~$142.82) and 13.81% above its 200-day SMA (~$129.48): a textbook orderly uptrend, with the moving averages stacked in the right order and no sign of the parabola that usually precedes a sharp reversal. Momentum is steady rather than hot — +1.49% one week, +2.95% one month, +7.84% three months, +10.3% six months. Entry-timing implication: this is not an oversold entry, and buying within 4% of the $153.67 52-week high leaves little technical cushion. RSI at 54 means the stock is not stretched, and the wide 13.8% gap to the 200-day means a normal pullback would be noise rather than a trend break — the 50-day around $142.80 is the first meaningful support, and a dip into the $138-143 zone would offer materially better risk/reward than chasing at $147.36. There is no technical reason to avoid the name; there is also no technical reason to rush.
- OPEC+ supply management and geopolitical risk premiums have put a floor under crude, and that floor is the single largest swing factor in EOG's realizations and earnings — the entire 2026 revenue and EPS inflection is levered to it.
- Henry Hub natural gas volatility: EOG's gas and NGL volumes mean that even with oil stable, domestic gas swings inject quarterly earnings noise that has nothing to do with operational execution.
- Oilfield service cost inflation and labor constraints across the E&P sector cap margin upside industry-wide — EOG is out-executing here (roughly 15% Delaware Basin well cost reduction), which is a relative tailwind, but it is swimming against a rising sector cost tide.
- Monetary policy and the cost of capital: a higher-for-longer rate environment raises discount rates applied to capital-intensive E&Ps, though EOG's 0.259 debt-to-equity, $4.907B of cash against $7.899B of long-term debt, and 1.851 current ratio largely insulate it from credit-market tightening.
- Sector rotation and EOG's 0.272 beta: within energy, EOG trades as a low-beta, high-return-of-capital name. That attracts income and quality flows in risk-off tapes but limits torque if energy leads a cyclical risk-on rally — the same beta that dampens drawdowns dampens upside.
- Q3 2026 earnings, expected early-to-mid November 2026 — the key proof point on capex pacing, full-year volume guidance, and how much of the Q1/Q2 2026 revenue surge was volume and efficiency versus realized price.
- Continued execution on the $11.7B remaining share repurchase authorization as of 2026-06-30 — roughly 15% of the $78.5B market cap, which is a meaningful structural bid under the stock if deployed steadily.
- Operational and inventory updates at late-autumn investor forums, including multi-basin inventory life and international exploration milestones in Trinidad and Australia.
- Further capital-efficiency gains in the Delaware Basin (already roughly 15% well cost reduction) flowing through to faster payouts and higher free cash flow per well.
- Upward earnings revision momentum: with 38 Buy ratings against 27 Holds and a $159.85 consensus target, any upward revision to the $16.692 next-FY EPS estimate would pull the multiple math in EOG's favor.
- Commodity price reversal is the dominant risk and it is double-barreled: falling oil or gas prices compress EPS and compress the multiple at the same time, and EOG's 2026 inflection is substantially price-levered.
- Consensus next-FY EPS of $16.692 is an estimate, not a fact. If it slips toward $13-14, the 8.83x forward P/E becomes roughly 10.5-11x and the 'cheap on forward' argument evaporates — the stock would then be priced at its historical average on lower earnings.
- Below-the-line volatility is a proven risk: Q4 2025 showed net income of $701M on $2.489B of operating income, roughly $1.0-1.2B of charges versus a normal $600-800M gap. Impairments, derivative marks, or tax items can gap reported EPS well below the operating reality in any given quarter.
- Long-term debt stepped up from $3.458B at 2025-06-30 to $7.667B at 2025-09-30 alongside a ~$5.9B jump in total assets, consistent with a debt-funded acquisition or asset purchase that the research brief does not explain. Integration risk, purchase-price quality, and any change to the capital-return cadence from that transaction are unquantified here.
- Valuation cushion has thinned: at 11.41x TTM P/E and 2.93x sales, EOG trades modestly above its own 5-year averages (10.47x / 2.74x), and at $147.36 it sits within roughly 4% of its 52-week high of $153.67 — a lot of the good news is already in the price.
- Longer-term terminal demand risk for hydrocarbons and the pace of the energy transition remain a structural overhang on the multiple the market is willing to award E&P cash flows, regardless of near-term execution.
EOG is a genuinely well-run, low-leverage E&P that just printed a real inflection — Q2 2026 revenue of $8.62B (roughly +61% year-over-year), $5.15 of diluted EPS, and $2.887B of free cash flow in a single quarter, backing an 8.6% trailing FCF yield, a 2.917% dividend, and $11.7B of remaining buyback authorization against a $78.5B market cap. The honest caveat is that the inflection is commodity-price-levered, not purely operational, and at $147.36 the stock is near its 52-week high and modestly above its own 5-year average P/E on trailing numbers — so you are buying good cash returns at a fair-to-slightly-cheap price, not a distressed one. At 8.83x forward EPS and 5.75x EV/EBITDA with net debt of roughly $3.0B, the downside is cushioned, but the upside to my $155 fair value is only about 5% plus the dividend. Own it for the capital-return floor and balance-sheet quality; add on commodity-driven weakness rather than strength. This is analysis, not personalized financial advice.
I apply a 9.3x P/E to next-FY consensus EPS of $16.692, giving $155.24 — a deliberate slight discount to EOG's own 5-year average P/E of 10.47x because current earnings sit above mid-cycle commodity pricing and the market will not capitalize peak-levered earnings at a full historical multiple. Two cross-checks land in the same neighborhood: 6.0x EV/EBITDA on trailing EBITDA of about $14.18B (derived from the 5.746x EV/EBITDA and roughly $3.0B of net debt) yields about $154/share, and an 8% FCF yield on roughly $6.3B of normalized mid-cycle free cash flow yields about $148/share. Weighting the earnings-based method most heavily because the balance sheet and capital-return program support a durable multiple, I settle on $155 as of 2026-09-13, roughly 5% above the then-current $147.36 price before the 2.917% dividend.
The 73.2 / 'Good Fundamentals' band is a fair read and my independent work lands within a few points of it, so Agree rather than a hedge. The 93.2 financial-health score is well earned (0.259 debt-to-equity, $4.907B cash against $7.899B long-term debt, 1.851 current ratio), and the -3.55% accruals ratio as of 2026-06-30 confirms reported earnings are cash-backed rather than accrual-inflated. The 100 growth score is real but backward-looking and should be discounted: it is substantially a commodity-price artifact of a roughly 61% year-over-year revenue jump, not evidence of structural share gains, so I would nudge the growth leg down. Offsetting that, the formula cannot see that Q4 2025's $1.30 EPS was crushed by roughly $1.0-1.2B of below-the-line charges (operating income of $2.489B against net income of $701M), which inflates the trailing 11.41x P/E — normalize that quarter and the trailing multiple is near the 10.47x five-year average, which argues for a slightly higher quality/valuation read. Importantly, the cyclical-trough caveat in the methodology does not apply here: EOG is near a cyclical high, not a trough, so the top-decile growth score should be treated as a peak-condition reading to fade, not a value signal to chase. Net: roughly the same score, same band, with the composition of the number viewed differently.
AI-generated analysis for informational purposes only, not financial advice.